Technetium-99 methylene diphosphonate - Chengdu Yunke PharmaceuticalsAlternative Names: 99 tc MDP; Tc99 MDP; Technetium-99 conjugated with methylene diphosphonate; Technetium[99Tc] Methylenediphosphonate; YunKe
Latest Information Update: 03 May 2016
At a glance
- Originator Chengdu Yunke Pharmaceutical
- Class Anti-inflammatories; Heavy metals; Imaging agents; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds
- Mechanism of Action Cytokine inhibitors; Immunomodulators; Osteoclast inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Rheumatoid arthritis